Search Results - hynda+kleinman

3 Results Sort By:
Star, Branched, and Graft Polymers in Binders for Inkjet Additive Manufacturing for Personalized Dosage Tablets
THE CHALLENGE A major problem posed by the pharmaceutical industry is giving effective dosages while not giving excessive amounts of a particular drug. An estimated 80% of side effects in humans and animals are a direct result of inaccurate dosing because varying weights in patients. Additive manufacturing has emerged as a very promising method to...
Published: 1/31/2024   |   Inventor(s): Emily Wilts, Timothy Long, Christopher Williams, Da Ma
Keywords(s):  
Category(s): Technology Classifications > Additive Manufacturing, Technology Classifications > Biomedical, Technology Classifications > Chemicals/Materials, Technology Classifications > Pharmacology and Therapeutics
Compositions and Methods for Inhibiting Vascular Channels and Methods of Inhibiting Proliferation
Angiogenesis, the recruitment of new blood vessels, is recognized as an important factor in tumor proliferation in many types of cancer. It is generally accepted that therapeutic approaches that inhibit angiogenesis effectively limit, or even prevent, the formation of solid tumors. It has also been shown that anti-angiogenic therapeutics allow conventional...
Published: 7/25/2024   |   Inventor(s): Paul Clement, Hartmut Hanauske-abel, Edith Wolff, Hynda Kleinman
Keywords(s): CBXXXX, CXXXXX, Vulvar cancer
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Oncology
Laminin A Peptides
This invention relates to peptides and derivatives thereof having laminin-like activity, as well as a pharmaceutical composition of the peptide. The peptides claimed include Serine-Isoleucine-Lysine-Valine-Alanine-Valine (SIKVAV). Methods for promoting increased adhesion and migration of epithelial cells is also disclosed. The peptides have wide usage...
Published: 7/25/2024   |   Inventor(s): Hynda Kleinman
Keywords(s): CC3XXX, CCXXXX, CXXXXX
Category(s): Collaboration Sought > Licensing, TherapeuticArea > Oncology, Application > Research Materials